We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Doctor-Patient Communication in Spanish

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00187785
Recruitment Status : Terminated
First Posted : September 16, 2005
Last Update Posted : January 18, 2006
Information provided by:

Study Description
Brief Summary:
Does use of a translator or use of less than perfect Spanish diminish provider-patient communication compared to a native speaker.

Condition or disease Intervention/treatment
Upper Respiratory Infection Hypertension Diabetes Behavioral: Spanish speaker level

Detailed Description:
Spanish speaking drop-in patients will be consented then randomized to receive care by a native Spanish speaker, an English speaker using a translator, or an English speaker with intermediate Spanish skills using Spanish. After the visit, the researcher will enquire about patient satisfaction, when the next appointment is, whether medication has been changed, and what instructions their provider gave them. Each provider will do a similar questionnaire. A blinded researcher will score a concordance of plans between provider and patient to see if there is a significant difference in retained information between the groups.

Study Design

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 100 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Educational/Counseling/Training
Official Title: Doctor-Patient Communication in Spanish
Study Start Date : September 2005
Estimated Study Completion Date : December 2006
Arms and Interventions

Outcome Measures

Primary Outcome Measures :
  1. retention of medical information

Secondary Outcome Measures :
  1. patient satisfaction

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Spanish speaker

Exclusion Criteria:

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00187785

United States, California
UMC Family Health Center
Fresno, California, United States, 93702
Sponsors and Collaborators
University of California, San Francisco
Principal Investigator: Roger B Mortimer, MD Department of Family Practice
More Information

ClinicalTrials.gov Identifier: NCT00187785     History of Changes
Other Study ID Numbers: UMC200552
First Posted: September 16, 2005    Key Record Dates
Last Update Posted: January 18, 2006
Last Verified: August 2005

Keywords provided by University of California, San Francisco:

Additional relevant MeSH terms:
Respiratory Tract Infections
Respiratory Tract Diseases